Author: Jon Lorsch

Headshot of NIGMS Director Dr. Jon Lorsch.

As NIGMS director, Jon oversees the Institute’s research, training, and other programs. He’s committed to engaging the scientific community on a wide range of topics, including funding policies and trends, research evaluation, and workforce development and diversity.

Posts by Jon Lorsch

Dorit Zuk Named NIGMS Acting Deputy Director

1 comment
Headshot of Dr. Dorit Zuk.

I’m pleased to tell you that Dorit Zuk has agreed to serve as acting deputy director of NIGMS upon Judith Greenberg’s retirement at the end of the month.

Dorit has served in several leadership roles at both NIGMS and NIH. She’s been the director of our Division of Genetics and Molecular, Cellular, and Developmental Biology (GMCDB) since early 2016. Before joining NIGMS, she was director of the former Office of Policy, Communications and Strategic Alliances at NIH’s National Center for Advancing Translational Sciences. Prior to that, she was the science policy advisor to the NIH deputy director for extramural research.

Continue reading “Dorit Zuk Named NIGMS Acting Deputy Director”

NIGMS Deputy Director Judith Greenberg to Retire

5 comments
Headshot of Dr. Judith Greenberg.

I’d like to share with you the bittersweet news that our deputy director, Judith H. Greenberg, is retiring at the end of the month after 45 years of service to NIH, most of which was spent right here at NIGMS. Judith has been a vital part of the NIGMS leadership team and an invaluable advisor to me since I came on board as NIGMS director.

Continue reading “NIGMS Deputy Director Judith Greenberg to Retire”

Developing a Culture of Safety in Biomedical Research Training

2 comments

NIGMS is committed to supporting safety in the nation’s biomedical research and training environments. Last April, we shared with you resources for enhancing lab safety in biomedical research training environments. Now, in a perspective in the current issue of Molecular Biology of the Cell (MBoC), we focus on strategies for improving laboratory safety. Some of these strategies are also applicable to other forms of safety including the prevention of harassment, intimidation, and discrimination. We frame the problem of laboratory safety using a number of recent examples of tragic accidents, highlight some of the lessons that have been learned from these and other events, discuss what NIGMS is doing to address problems related to laboratory safety, and outline steps that institutions can take to improve their safety cultures.

Continue reading “Developing a Culture of Safety in Biomedical Research Training”

What Can We Do to Combat Anti-Black Racism in the Biomedical Research Enterprise?

20 comments

The recent deaths of George Floyd, Ahmaud Arbery, and Breonna Taylor, in addition to the disproportionate burden of COVID-19 on African Americans, are wrenching reminders of the many harms that societal racism, inequality, and injustice inflict on the Black community. These injustices are rooted in centuries of oppression—including slavery and Jim Crow, redlining, school segregation, and mass incarceration—that continue to influence American life, including the biomedical research enterprise. Despite leading an NIH Institute whose mission includes building a diverse scientific workforce, at NIGMS we’ve struggled with what an adequate response to this moment would be, knowing that the systems that mediate the distinct and disparate burdens Black students, postdocs, and scientists face are complex and often aren’t easily moved with the urgency that they demand. With that in mind, below we share thoughts on what each of us who is in the majority or in a position of power can do to help break the cycles of racial disparities that are woven into the fabric of the biomedical research enterprise and that limit opportunities Link to external web site for Black scientists Link to external web site.

Institutional structures, policies, and cultures Link to external web site, including those in the biomedical research enterprise, all contribute to racial inequality and injustice. This fact was laid bare for us by the responses to the request for information (RFI) we issued in 2018 on strategies to enhance successful postdoctoral career transitions to promote faculty diversity. Respondents cited bias and discrimination—including racism—most frequently as a key barrier to postdoctoral researchers attaining independent faculty positions.

Continue reading “What Can We Do to Combat Anti-Black Racism in the Biomedical Research Enterprise?”

Seeking Feedback on Our New Strategic Plan

0 comments

UPDATE: The deadline for responding to the request for information has been extended to July 31.

As I described in my last post, we recently released a progress and outcomes report [PDF] highlighting the work we’ve done to meet the goals and objectives of the NIGMS 2015-2020 strategic plan [PDF].

We’re now beginning development of a new strategic plan that will describe NIGMS’ overarching goals, strategic objectives, and implementation tactics in support of the Institute’s mission over the next 5 years.

Continue reading “Seeking Feedback on Our New Strategic Plan”

Reflecting on Our Strategic Priorities

0 comments

In my first post as NIGMS director in 2013, I discussed the need to develop a new strategic plan to guide our efforts and to ensure that we invest taxpayer money as efficiently and effectively as possible. Our current strategic plan emerged as a product of collaboration between all functional units of our Institute, with valuable input from external stakeholders, and it’s been used to guide management decisions at NIGMS for the last 5 years.

Since publication of this strategic plan in 2015, the Institute has undertaken programmatic and organizational changes to better achieve the goals set forth in the plan. I therefore wanted to reflect on these activities as we consider our priorities for the next 5 years.

Continue reading “Reflecting on Our Strategic Priorities”

New Webinar Series for the NIGMS Training Community

4 comments

UPDATE: Additional webinars have been announced. View the full schedule.

We’re pleased to announce a new webinar series for students, postdocs, and faculty. Each hour-long webinar will include a 10- to 15-minute presentation by the speaker followed by a moderated question and answer session. Our hope is that these webinars will enhance our trainees’ ongoing learning experiences. 

The webinar series kicks off next Monday, May 4, and a tentative list of dates and speakers is below. As plans are finalized, additional details will be posted on our website.

Continue reading “New Webinar Series for the NIGMS Training Community”

New NIGMS Web Resource on Safety in the Lab and Other Training Environments

0 comments

The safety of trainees and other lab workers from accidents, violence, harassment, and inappropriate behavior is a high priority for NIGMS. Because the Institute has such a large training and workforce development portfolio, we feel that we should play a central role in promoting the development of a robust culture of safety in biomedical research training environments.

As part of this effort, we recently announced the availability of supplements for research education, training, and career development grants to enhance laboratory safety curricula and to build a culture of safety in biomedical research training environments (NOT-GM-20-016). To provide additional resources to enhance safety, we have now launched an NIGMS website highlighting laboratory safety training and guidelines. On this page, you’ll find links to a number of online resources including:

Continue reading “New NIGMS Web Resource on Safety in the Lab and Other Training Environments”

NIGMS Virtual Learning Resources for Scientists at All Career Stages

1 comment

To assist with virtual learning during the COVID-19 pandemic, we’d like to remind you of the valuable resources NIGMS supports for our trainee and educator communities. These resources apply to all levels, ranging from community college students to faculty.

Continue reading “NIGMS Virtual Learning Resources for Scientists at All Career Stages”

Application and Funding Trends in Fiscal Year 2019

2 comments

UPDATE: Figure 2 of this post was updated slightly in March 2021 to reflect NIGMS-supported Early Stage Investigator counts more accurately.

On December 20, 2019, the Further Consolidated Appropriations Act, 2020 Link to external web site, was signed into law. The appropriation provides NIGMS with a budget of $2,937,218,000 in Fiscal Year (FY) 2020, a 2.2% increase over the FY 2019 appropriation. With this increased budget, NIGMS is committed to providing taxpayers with the best possible returns on their investments in fundamental biomedical research [PDF]. As part of this commitment to stewardship [PDF], we regularly monitor trends in our funding portfolio.

NIGMS maintains a diversified investment portfolio, supporting a wide range of research topics and investigators. Recent NIGMS and NIH programs and policies aim to increase the number of different investigators funded, and to maintain researchers’ funding stability over time. Consistent with our focus on supporting a broad group of investigators, we monitor two statistics that describe our investigator pool.

Continue reading “Application and Funding Trends in Fiscal Year 2019”